Jared Whitlock
Reporter
Phone: 858-634-4636 Extension: 3130
Recent Stories
Tri-City to Reconsider Suspension of Mental Health Unit
The Tri-City Healthcare District board will soon reconsider a decision to suspend operations of the center’s inpatient Behavioral Health Unit and Crisis Stabilization Unit.
DJO Moving to Texas, Cutting 187 Local Jobs
DEVICES: 300 Jobs to Remain; Co. Consolidating Operations
DJO Global, which grew from a garage startup to become one of North County’s largest private employers, is laying off 187 local employees and relocating its headquarters to Dallas, Texas.
Synthorx Hires a CMO
Joseph Leveque has joined San Diego biotech Synthorx as chief medical officer.
Wave of Investment Has Life Sciences Swimming in Cash
Cash is pouring into early-stage San Diego life sciences, with 2018 shaping up as a banner year, according to observers.
UC San Diego Health, Rancho Family Medical Group Enter Affiliation
Rancho Family Medical Group, or RFMG, will be able to tap into services from UC San Diego Health through a new affiliation.
Venter Retires as Chairman of Synthetic Genomics Board
J. Craig Venter has retired as chairman of the Synthetic Genomics board, according to a company news release.
Local Device Cos. See Solid Quarterly Results
MEDICINE: National Picture Expecting 4% to 5% Growth
Four major medical device companies based in San Diego recently delivered strong quarterly results, lifting their stocks and growth outlooks.
La Jolla Institute Researcher Lands $2.24M Grant
Ferhat Ay with the La Jolla Institute for Allergy and Immunology was awarded a $2.24 million grant to for research into genetic variation and disease risk.
Rady’s Expands Services in Riverside with New Facility
Rady Children’s Hospital-San Diego recently held a grand opening for a medical plaza in southwest Riverside County, with the dual goal of consolidating outpatient operations and reaching more patients.
Partnerships, Pipeline Put Inovio in Good Position
PHARMA: Versatile Co. Takes On Cancers, Infectious Diseases
Inovio Pharmaceuticals Inc. has about 300 employees, tenfold that of 2009. Most of the scaling up occurred in the last few years to support a growing pipeline of therapies targeting cancers and infectious diseases.
